相关实验视频
Updated: Jul 10, 2025

15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
9.6K
肌肉参与肌缩性侧面硬化症:了解病变发生和推进治疗方法
1School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Biomolecules
|November 25, 2023
概括
肌缩侧面硬化症 (ALS) 是一种进展性神经肌肉疾病,导致运动神经元损失和肌肉缩. 这篇评论强调了肌肉肌肉.
科学领域:
- 神经学 神经学
- 肌肉生理学 肌肉生理学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种致命的神经肌肉疾病,其特征是选择性运动神经元损失.
- 关键特征包括肌肉参与,缩和渐进性,影响日常活动.
- 传统的研究集中在中枢神经系统,但肌肉研究正在获得显著的兴趣.
研究的目的:
- 为了回顾氨缩侧面硬化症 (ALS) 的定义特征.
- 阐明肌肉组织在ALS病变发生中的关键作用.
- 检查针对ALS肌肉功能的近期治疗策略.
主要方法:
- 审查关于肌缩侧面硬化症 (ALS) 的现有文献.
- 分析着重于肌肉中的分子机制的研究.
- 对ALS患者肌肉功能障碍的治疗干预措施和动物模型的检查.
主要成果:
- ALS涉及运动神经元的渐进性退化,导致肌肉缩和.
- 肌肉病理在ALS进展和症状严重程度方面发挥着重要作用.
- 新兴研究正在探索改善肌肉功能和减轻疾病影响的疗法.
结论:
- 了解肌肉的作用对于开发有效的ALS治疗至关重要.
- 准肌肉功能为ALS的治疗干预提供了一个有希望的途径.
- 对肌肉特异性机制的进一步研究可能会导致改善患者的治疗结果.
相关概念视频
Cross-bridge Cycle
117.5K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.5K
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Parkinson's Disease: Overview
557
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
557
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
684
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
684
Myasthenia Gravis: Diagnostic Tests
890
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
890

